Biocytogen
Biocytogen is a global biotech company advancing antibody drug discovery and development. Through RenBiologics™, it provides access to 1M+ fully human antibody sequences against 1,000+ druggable targets, supporting monoclonal, bispecific, multispecific, ADC, VHH, and TCR-mimic antibody programs. Leveraging gene-editing expertise, Biocytogen pioneered humanized knock-in models and offers 4,000+ BioMice™ models, along with in vivo, ex vivo, and in vitro pharmacology, and custom gene-editing services.
